Huisartsenbrochure Pulmonale Hypertensie

Pulmonale Hypertensie 1. Austin ED, Loyd JE, Phillips JA . Genetics of pulmonary arterial hypertension. Semin Respir Crit Care Med 2009 Aug;30(4):386-98. 2. Austin ED, Loyd JE. Heritable Forms of Pulmonary Arterial Hypertension. Semin Respir Crit Care Med 2013;34(05):568-580. 3. Bogaard HJ, Natarajan R, Mizuno S, et al. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. Am J Respir Crit Care Med 2010;182:652-60. 4. Bogaard HJ, Vonk Noordegraaf A. Differentiating Pulmonary Hypertension: it’s not all Pulmonary Hypertension. VU University Medical Center, dept of Pulmonary Medicine, Amsterdam, the Netherlands. 5. Bogaard HJ, Bresser P, Grunberg K, Vonk Noordegraaf A. Version 20131122 NRS Roadmap Pulmonary Hypertension report. 6. Bogaard HJ, Vonk Noordegraaf A, Voelkel NF. Right-Sided Heart Failure in Chronic Lung Diseases and Pulmonary Arterial Hypertension; Heart failure and cardiomyopathy chapter 84. 7. D’Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343-9. 8. Geneesmiddelenbulletin 2013;47:123-130. 9. Gomez-Arroyo JG et al. Inhaled iloprost reverses established fibrosis and improves right ventricular dysfunction by reducing connective tissue growth factor expression and collagen synthesis. Abstract ATS A3984, Philidelphia. 2013. 10. Hoeper MM, Barst RJ, Bourge RC, et al. Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation 2013;127:1128-38. 11. Hoeper MM, Barbera JA, Channick RN, Hassoun PM, Lang IM, Manes A, et al. Diagnosis, assessment, and treatment of non- pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol 2009;54:S85-96. 12. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006;173:1023-30. 13. Kiely DG, Elliot CA, Sabroe i, Condliffe R. Pulmonary hypertension: diagnosis and management. BMJ 2013;346:f2028. 14. Minai OA, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest 2010;137:39S-51S. 15. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton D, Ghofrani A. Updated Clinical classification op pulmonary hypertenion. Journal of the American College of Cardiology Vol 62, no25, Suppl D, 2013. 16. Strange G, Playford D, Stewart S, Deague JA, Nelson H, Kent A, et al. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart 2012;98:1805-1811. 17. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 2007;30:1103-10. 18. Tonelli AR, Arelli V, Minai OA, Newman J, Bair N, Heresi GA, et al. Causes and circumstances of death in pulmonary arterial hypertension. Am J Respi Crit care Med 2013;188:365-369. 19. Tueller C, Stricker H, Soccal P, TammM, Aubert JD, Maggiorini M, et al. Epidemiology of pulmonary hypertension: new data from the Swiss registry. Swiss MedWkly 2008;138:379-84. 20. Vonk Noordegraaf A, Boonstra A, Konings TC, Marques KMJ en Bogaard HJ. Diagnostiek en behandeling van pulmonale hypertensie: Stand van zaken. Richtlijnen/standaarden 21. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A. ESR/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. 2015. 22. Douwes JM, Roofthooft MTR, Berger RMF. Standaard diagnostiek en behandeling van pulmonale hypertensie bij kinderen. Netwerk voor Pulmonale Hypertensie op de Kinderleeftijd. 2013. 23. Vajda I. Visiedocument Concentratie en organisatie van zorg bij zeldzame aandoeningen. VSOP. 2015 . 24. Hendriks S. Generieke zorgthema Huisartsgeneeskundige zorg. VSOP. 2014 . Literatuurlijst 16